Pediatric Rheumatology BioMed Central Commentary Open Access A peripatetic pediatrician's journey into pediatric rheumatology: Part II Earl J Brewer* Email: Earl J Brewer* -
[email protected] * Corresponding author Published: 21 June 2007 Received: 19 June 2007 Accepted: 21 June 2007 Pediatric Rheumatology 2007, 5:14 doi:10.1186/1546-0096-5-14 This article is available from: http://www.ped-rheum.com/content/5/1/14 © 2007 Brewer; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Earl Brewer discusses his journey into pediatric rheumatology from 1958 to retirement in 1990 in three parts. Part II: The PRCSG and the Park City meetings in children. I conducted the study at the Ben Taub Hospi- in the US tal in Houston. It was published in Arthritis and Rheuma- IV Pediatric Rheumatology Collaborative Study Group tism in 1968. The study was able to show that (PRSCG) – 1973 indomethocin was superior to acetaminophen in control- The beginning of the PRSCG was part of the evolving plan ling fever. This was a short usage study, but no adverse for the future of pediatric rheumatology in the US. I was reactions occurred in the short dosage regimen. This impressed with the work of Maxwell Finland in Boston in study, however, did not address the problem of obtaining an earlier era when he cobbled together a group of clini- approval for the use of indomethacin in children.